Variant · Snv
TAF8 NM_138572.3(TAF8):c.489G>A (p.Pro163=)
CI-VAR-00241572Explore in graph →p.Pro163=NM_138572.3:c.489G>AClinVar 1698453 rs554917914
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1698453 | Pathogenic | no assertion criteria provided | 0 | Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy; Papillary renal cell carcinoma type 1; Nonpapillary renal cell carcinoma | germline | 2 | Jul 28, 2022 | clinvar |